Cardinal Health (NYSE:CAH) shares dropped 9% intra-day on Tuesday after the healthcare services provider posted fourth-quarter revenue that missed Wall Street expectations, even as it raised its fiscal 2026 earnings guidance.
Fourth-quarter revenue came in at $60.2 billion, flat compared to the prior year and below the $60.92 billion consensus estimate. Excluding the impact of a previously disclosed contract expiration with OptumRx, revenue rose 21% year-over-year.
Adjusted earnings were $2.08 per share, topping estimates of $2.03 and marking a 13% annual increase. Non-GAAP operating earnings climbed 19% to $719 million, with all five operating segments delivering double-digit profit growth.
For fiscal 2025, the company generated $222.6 billion in revenue, down 2% year-over-year, but up 18% excluding the OptumRx contract change. Adjusted EPS for the year increased 9% to $8.24.
Cardinal Health raised its fiscal 2026 adjusted EPS outlook to $9.30-$9.50, above its prior range of $9.10-$9.30 and ahead of analyst expectations of $9.25.
